Jingjin Zhu1, Mei Liu2, Xiru Li3. 1. School of Medicine, Nankai University, Tianjin, China. 2. Department of Pathology, Chinese People's Liberation Army General Hospital, Beijing, China. 3. Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Abstract
Background and Objective: Pathology is the gold standard criteria for breast cancer diagnosis and has important guiding value in formulating the clinical treatment plan and predicting the prognosis. However, traditional microscopic examinations of tissue sections are time consuming and labor intensive, with unavoidable subjective variations. Deep learning (DL) can evaluate and extract the most important information from images with less need for human instruction, providing a promising approach to assist in the pathological diagnosis of breast cancer. To provide an informative and up-to-date summary on the topic of DL-based diagnostic systems for breast cancer pathology image analysis and discuss the advantages and challenges to the routine clinical application of digital pathology. Methods: A PubMed search with keywords ("breast neoplasm" or "breast cancer") and ("pathology" or "histopathology") and ("artificial intelligence" or "deep learning") was conducted. Relevant publications in English published from January 2000 to October 2021 were screened manually for their title, abstract, and even full text to determine their true relevance. References from the searched articles and other supplementary articles were also studied. Key Content and Findings: DL-based computerized image analysis has obtained impressive achievements in breast cancer pathology diagnosis, classification, grading, staging, and prognostic prediction, providing powerful methods for faster, more reproducible, and more precise diagnoses. However, all artificial intelligence (AI)-assisted pathology diagnostic models are still in the experimental stage. Improving their economic efficiency and clinical adaptability are still required to be developed as the focus of further researches. Conclusions: Having searched PubMed and other databases and summarized the application of DL-based AI models in breast cancer pathology, we conclude that DL is undoubtedly a promising tool for assisting pathologists in routines, but further studies are needed to realize the digitization and automation of clinical pathology. 2022 Gland Surgery. All rights reserved.
Background and Objective: Pathology is the gold standard criteria for breast cancer diagnosis and has important guiding value in formulating the clinical treatment plan and predicting the prognosis. However, traditional microscopic examinations of tissue sections are time consuming and labor intensive, with unavoidable subjective variations. Deep learning (DL) can evaluate and extract the most important information from images with less need for human instruction, providing a promising approach to assist in the pathological diagnosis of breast cancer. To provide an informative and up-to-date summary on the topic of DL-based diagnostic systems for breast cancer pathology image analysis and discuss the advantages and challenges to the routine clinical application of digital pathology. Methods: A PubMed search with keywords ("breast neoplasm" or "breast cancer") and ("pathology" or "histopathology") and ("artificial intelligence" or "deep learning") was conducted. Relevant publications in English published from January 2000 to October 2021 were screened manually for their title, abstract, and even full text to determine their true relevance. References from the searched articles and other supplementary articles were also studied. Key Content and Findings: DL-based computerized image analysis has obtained impressive achievements in breast cancer pathology diagnosis, classification, grading, staging, and prognostic prediction, providing powerful methods for faster, more reproducible, and more precise diagnoses. However, all artificial intelligence (AI)-assisted pathology diagnostic models are still in the experimental stage. Improving their economic efficiency and clinical adaptability are still required to be developed as the focus of further researches. Conclusions: Having searched PubMed and other databases and summarized the application of DL-based AI models in breast cancer pathology, we conclude that DL is undoubtedly a promising tool for assisting pathologists in routines, but further studies are needed to realize the digitization and automation of clinical pathology. 2022 Gland Surgery. All rights reserved.
Entities:
Keywords:
Breast cancer; artificial intelligence (AI); deep learning (DL); digital pathology
Authors: Baris Gecer; Selim Aksoy; Ezgi Mercan; Linda G Shapiro; Donald L Weaver; Joann G Elmore Journal: Pattern Recognit Date: 2018-07-20 Impact factor: 7.740
Authors: Mitko Veta; Paul J van Diest; Stefan M Willems; Haibo Wang; Anant Madabhushi; Angel Cruz-Roa; Fabio Gonzalez; Anders B L Larsen; Jacob S Vestergaard; Anders B Dahl; Dan C Cireşan; Jürgen Schmidhuber; Alessandro Giusti; Luca M Gambardella; F Boray Tek; Thomas Walter; Ching-Wei Wang; Satoshi Kondo; Bogdan J Matuszewski; Frederic Precioso; Violet Snell; Josef Kittler; Teofilo E de Campos; Adnan M Khan; Nasir M Rajpoot; Evdokia Arkoumani; Miangela M Lacle; Max A Viergever; Josien P W Pluim Journal: Med Image Anal Date: 2014-11-29 Impact factor: 8.545
Authors: Brandon S Sheffield; Zuzana Kos; Karama Asleh-Aburaya; Xiu Qing Wang; Samuel Leung; Dongxia Gao; Jennifer Won; Christine Chow; Rakesh Rachamadugu; Inge Stijleman; Robert Wolber; C Blake Gilks; Nickolas Myles; Tom Thomson; Malcolm M Hayes; Philip S Bernard; Torsten O Nielsen; Stephen K L Chia Journal: Breast Cancer Res Treat Date: 2016-02-04 Impact factor: 4.872
Authors: Mei-Yin C Polley; Samuel C Y Leung; Lisa M McShane; Dongxia Gao; Judith C Hugh; Mauro G Mastropasqua; Giuseppe Viale; Lila A Zabaglo; Frédérique Penault-Llorca; John M S Bartlett; Allen M Gown; W Fraser Symmans; Tammy Piper; Erika Mehl; Rebecca A Enos; Daniel F Hayes; Mitch Dowsett; Torsten O Nielsen Journal: J Natl Cancer Inst Date: 2013-11-07 Impact factor: 13.506
Authors: Nicolas Coudray; Paolo Santiago Ocampo; Theodore Sakellaropoulos; Navneet Narula; Matija Snuderl; David Fenyö; Andre L Moreira; Narges Razavian; Aristotelis Tsirigos Journal: Nat Med Date: 2018-09-17 Impact factor: 53.440